Literature DB >> 7517252

The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.

H J Harn1, L I Ho, C P Yu, M W Wang, H S Lee, J J Lin, W H Lee, N R Isola, D L Cooper.   

Abstract

The interaction of the cell surface receptor CD44 molecular with its ligands (addressin, extracellular matrix etc.,) plays an important role in fulfilling the lymphocyte homing and immune reaction. Recently alternatively spliced products of CD44 gene are found to be involved in tumor metastasis as well. Our report found that CD44 prototype RNA (CD44S) was present in all five tumor cell lines. Isoform CD44 RNA (CD44V) was recognized in three metastasized hepatocellular carcinoma cell lines, J5, HCC36, HEP3B. In addition, the J5 CD44 RNA isoform expressed two distinct transcripts which are of the same size as MDA-231 breast tumor cell line. The MDA-231 CD44 RNA variant (CD44V) has been confirmed to contain metastasis domain 4 and 5. It is implicated that the alternative RNA splicing may also play a major role in hepatocellular carcinoma metastasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517252

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  6 in total

1.  Relationship between expression of CD44v6 and nm23-H1 and tumor invasion and metastasis in hepatocellular carcinoma.

Authors:  Cheng-Zhi Xiao; Yi-Min Dai; Hong-Yu Yu; Jian-Jun Wang; Can-Rong Ni
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.

Authors:  Lu Zhang; Xiaoqiao Liu; Xuegong Zhang; Ronghua Chen
Journal:  Mol Genet Genomics       Date:  2015-12-28       Impact factor: 3.291

Review 3.  Molecular studies into the role of CD44 variants in metastasis in gastric cancer.

Authors:  H F Hsieh; J C Yu; L I Ho; S C Chiu; H J Harn
Journal:  Mol Pathol       Date:  1999-02

4.  Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion.

Authors:  Chonghui Cheng; Phillip A Sharp
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 5.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

6.  Immunodetection of nmt55/p54nrb isoforms in human breast cancer.

Authors:  M Pavao; Y H Huang; L J Hafer; R B Moreland; A M Traish
Journal:  BMC Cancer       Date:  2001-10-29       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.